{"podcast":{"title":"The Bio Report","slug":"the-bio-report-1092382","podcast_index_feed_id":1092382,"rss_url":"https://feed.podbean.com/thebioreport/feed.xml","website_url":"https://thebioreport.podbean.com","image_url":"https://pbcdn1.podbean.com/imglogo/image-logo/15149796/BRlogo_znb5nt.jpg","author":"Levine Media Group","episode_count":615,"summary":"The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/the-bio-report-1092382"},"episode":{"title":"Determining the Cause and Severity of Sepsis with a Point-of-Care Test","slug":"determining-the-cause-and-severity-of-sepsis-with-a-point-of-care-test","published_at":"2025-12-10T08:00:00+00:00","page_url":"https://stenobird.com/podcast/the-bio-report-1092382/determining-the-cause-and-severity-of-sepsis-with-a-point-of-care-test","show_page_url":"https://stenobird.com/podcast/the-bio-report-1092382","url":"https://thebioreport.podbean.com/e/determining-the-cause-and-severity-of-sepsis-with-a-point-of-care-test/","audio_url":"https://mcdn.podbean.com/mf/web/6itw222xrtjda9fb/BR-Tim_Sweeney-12-17-259hnqv.mp3","summary":"Sepsis remains one of medicine’s most intractable and costly problems, arising when an infection triggers a runaway immune response that damages organs long after a pathogen is controlled. It accounts for an estimated $53 billion in Medicare spending alone, yet more than a hundred drug trials have failed to yield a single approved drug that directly treats the underlying immune dysfunction. Inflam­matix, which grew out of work at Stanford University, has developed a point-of-care blood test to determine whether an infection is bacterial or viral, as well as the severity of the patient’s immune response to optimize treatment. We spoke to Tim Sweeney, CEO of Inflammatix, about the company’s TriVerity test for sepsis, how it works, and how it is used in an ER setting to determine who needs antibiotics, ICU‑level care, or a broader diagnostic workup.​","meta_description":"Sepsis remains one of medicine’s most intractable and costly problems, arising when an infection triggers a runaway immune response that damages organs lo…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2229,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/determining-the-cause-and-severity-of-sepsis-with-a-point-of-care-test/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-bio-report-1092382/determining-the-cause-and-severity-of-sepsis-with-a-point-of-care-test.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}